NHS Logo

Biosimilars /

Cornes, Paul (Oncologist),

Biosimilars / [E-Book] - First edition. - 1 online resource (70 pages) : illustrations (colour). - Fast facts . - Fast facts. .

Also issued in print: 2018.

Includes bibliographical references and index.

Biosimilars have been in clinical use for more than 10 years, and evidence from more than 700 million patient-days' exposure shows that approved biosimilars can be used as safely and effectively as their originator biologics. And yet concerns about these drugs persist, particularly in therapy areas where they are recent additions to the formulary. It is vital to address these concerns so that clinicians can prescribe biosimilars with confidence, realizing substantial cost savings and improving patient access to effective treatments. This book provides a comprehensive yet concise explanation of biosimilars: what they are, how they are regulated, and how they are used in clinical practice.

Specialized.

9781910797686 (PDF ebook) : No price No price


Pharmaceutical biotechnology.
Technology, Pharmaceutical.

QV 778
London Health Libraries Consortium Privacy notice and Membership terms and conditions